Latest Hereditary nonpolyposis colorectal cancer Stories
Lynch Syndrome is a heritable genetic mutation that causes colorectal, endometrial and other cancers. A cooperative study that included the University of Colorado Cancer Center, published in this month’s issue of the Journal of the National Cancer Institute, revises the risk of colorectal cancer down but other cancers up for women with Lynch Syndrome who have had endometrial cancer. “This new information helps patient care in two important ways. First, it helps us counsel women with...
Twenty-nine percent of patients with colorectal cancer in a nationally representative sample were diagnosed after an emergency, such as an obstruction or perforation of the bowel, according to data presented at the 11th Annual AACR International Conference on Frontiers in Cancer Prevention Research, held here Oct. 16-19, 2012. In addition, African-Americans and those living in high-poverty areas were more likely to present with an emergency diagnosis. "Overall, there are high rates of...
Lee Rannals for redOrbit.com - Your Universe Online Growing evidence is suggesting that aspirin, the pain reliever drug used to fend off aches and heart disease, may also be able to prevent cancer. Studies are showing that taking aspirin may reduce an individual's chances of developing colorectal cancer and maybe some other types of malignancies. Although the evidence is growing, so far it still hasn't outweighed the risks of prescribing aspirin to millions of healthy people....
The CRCgene database, which gathers all genetic association studies on colorectal cancer, allows for researchers to accurately interpret the risk factors of the disease and provides insight into the direction of further colorectal cancer research, according to a study published September 27 in the Journal of the National Cancer Institute. Approximately 950,000 new cases of colorectal cancer are diagnosed each year. The risk of developing the disease also increases with age, and as life...
An international team of researchers led by the University of Melbourne has used new technology to fast track the discovery of a breast cancer risk gene which could assist in the discovery of other cancer genes. Professor Melissa Southey of the Genetic Epidemiology Laboratory, Department of Pathology at the University of Melbourne, who led the study, said it was a significant discovery and the first breast cancer risk gene to be discovered using the latest genetic sequencing technology....
Unique Website offers need-to-know information and support about genetic testing. SALT LAKE CITY, (PRWEB) March 23, 2012 In conjunction with Colon Cancer Awareness Month in March, Myriad Genetics (Nasdaq:MGYN) announces the release of its new genetic testing support website: http://www.mySupport360.com. The site is a unique, personalized resource for information and encouragement about risk testing for hereditary forms of breast, ovarian and other types of cancers, including Hereditary...
ANN ARBOR, Mich., March 14, 2012 /PRNewswire/ -- Everist Genomics (EGI), a rapidly-growing personalized medicine company, today announced the launch of the world's first comprehensive companion diagnostics and prognostics portfolio to improve early diagnosis, management and treatment of patients with colorectal cancer. (Photo: http://photos.prnewswire.com/prnh/20120314/NY69822 ) (Logo: http://photos.prnewswire.com/prnh/20110110/NY26865LOGO ) The portfolio of four individual tests...
An international study led by the University of Melbourne has provided a clearer understanding of the cancer risks associated with the genetic mutation Lynch syndrome, a finding that could lead to earlier detection of a wide range of cancers in sufferers. People with Lynch syndrome have a genetic mutation that gives them a high risk of several types of cancer including bowel cancer. The genes that are damaged can’t repair any errors that occur in our DNA. The study, which has been...
In this News Digest: Summary of the first prospective study – published online February 13, 2012 in the Journal of Clinical Oncology – to provide strong evidence of increased breast and pancreatic cancer risk in individuals with Lynch syndrome, who carry certain inherited genetic mutations in DNA repair genes. The study is also the first to show that relatives of people with Lynch syndrome who do not carry these mutations have no increased risk of cancer. Quote for...
After a 20-year quest to find a genetic driver for prostate cancer that strikes men at younger ages and runs in families, researchers have identified a rare, inherited mutation linked to a significantly higher risk of the disease. A report on the discovery was published in the January 12, 2012 issue of the New England Journal of Medicine. UNC-Chapel Hill scientist Ethan Lange, PhD, was part of the team of investigators at the Johns Hopkins University School of Medicine, the University of...
